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INTRODUCTION
Phlegmasia cerulea dolens, which is the most severe 
clinical presentation of deep venous thrombosis and 
results from an almost complete occlusion of the major 
and collateral venous outflow routes from the extremity, 
is very rarely seen in children [1-6]. Here we present the 
treatment of severe thrombosis of the inferior vena cava 
and deep veins of both lower extremities in an 11-year-
old boy. 
CASE PRESENTATION
An 11-year-old male patient with Down syndrome 
was admitted to our hospital because of upper respirato-
ry tract infection accompanied by high fever. After 2 days 
of hospital stay he was discharged with recommendation 
for further outpatient treatment. Still, after 5 days he was 
again admitted to the hospital because of swelling of both 
lower extremities, primarily on the left side, and also of 
the scrotum and penis (Fig. 1A). This severe oedema clin-
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ically manifested as phlegmasia cerulea dolens. CT angiog-
raphy revealed thrombotic occlusion of the inferior vena 
cava (Fig. 1B) and bilateral occlusions of the external iliac 
and femoral veins, which on the left side was associated 
with thrombosis of superficial tributaries of the femoral 
vein. After consultation by paediatric cardiac surgeon, 
considering the fact that thrombotic material could not 
be removed surgically, the patient was managed with 
fibrinolytics (alteplase). However, fibrinolytic treatment 
was unsuccessful and the status of oedematous lower 
limbs deteriorated. Therefore we decided to perform per-
cutaneous mechanical thrombectomy with the use of the 
Aspirex®S thrombectomy device (Straub Medical AG, 
Wangs, Switzerland). 
INTERVENTION
Firstly, under sonographic control, we cannulated the 
right femoral vein with a 6F Brite tip® guiding catheter 
(Cordis, Fremont, CA, USA). We did not cannulate the 
popliteal vein because it was very narrow, about 2 mm 
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in diameter. Catheter angiography confirmed throm-
botic occlusion of the iliac vein and the inferior vena 
cava (Fig. 1C). With the use of a 260-cm-long AqWireTM 
hydrophilic guidewire (Covidien, ev3 Endovascular, Inc., 
Plymouth, MN, USA) and a vertebral diagnostic catheter 
we navigated through the occlusion to the right atrium 
and then to the left subclavian vein. We introduced the 
6F Aspirex®S and with the use of this device we removed 
thrombi from the inferior vena cava and from the right 
common and external iliac veins (Fig. 1D). Control angi-
ography revealed partially recanalised inferior vena cava 
(Fig. 1E). Of note, there were no anatomic abnormalities 
of the inferior vena cava, such as aplasia, septum or a web. 
We continued aspiration thrombectomy of the right iliac 
vein and inferior vena cava, and then we cannulated the 
left femoral vein with the 6F/45 cm Destination® guid-
ing sheath (Terumo, Tokyo, Japan). Through this sheath 
we performed thrombectomy with the Aspirex®S device 
of the left femoral and iliac veins. Catheter angiography 
demonstrated partial recanalisation of these veins (Fig. 
1F). Finally, we introduced the Fountain infusion cath-
eter (Merit Medical Systems, Inc., South Jordan, UT, 
USA), which is equipped with a system of gradient-sized 
holes enabling uniform dispersion of therapeutic agent. 
Through this catheter, over the entire length of the iliac 
veins, alteplase was administered for 48 h (initial dose 
3 mg, then 10 mg in infusion). We also administered 
a sub-therapeutic dose of low-molecular-weight heparin. 
This treatment was complicated by local bleeding (which 
required long compression and transfusion of blood) at 
the site of vascular access. After the treatment the patient 
improved clinically and control angiography demon-
strated patent inferior vena cava and both iliac veins 
and partial reduction of swelling of the scrotum (Fig. 2A 
and 2D). Still, after 4 days both iliac veins reoccluded. 
We again performed aspiration thrombectomy with the 
Aspirex®S device (Fig. 2B and 2C), which was followed 
by local intravenous administration of alteplase for 72 h. 
There were no complications associated with the second 
treatment. The treatment with alteplase was then fol-
lowed by administration of a low-molecular-weight hep-
arin. Although there were still residual thrombi and sten-
oses of the iliac veins, we decided not to implant stents, 
considering the fact that the patient was a child and even 
a properly implanted stent in a few years would be too 
small and result in a difficult-to-manage narrowing of 
the iliac vein. The patient was discharged after 15 days 
of hospitalisation (without swelling of lower extremi-
Fig. 1. A) Initial state of patient: large oedema of the lower limbs, scrotum and penis. B) CT angiography of the veins – visible large 
thrombus in distal part of the inferior vena cava (1), occlusion of the illiac veins. C) Venography of the external and common iliac 
vein – no flow of contrast, with a large thrombus (2). D) System of endovascular mechanical thrombectomy Aspirex advanced into 
the iliac veins (3). E) Venography of the partially recanalised inferior vena cava and iliac veins after the use of Aspirex (5) – visible 
residual 80-90% stenosis with a flow of contrast. F) Venography of the left external and common iliac veins (6) after thrombectomy 
with Aspirex system
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ties, and also of the scrotum and penis – Fig. 2E), with 
the recommendation of antithrombotic treatment with 
low-molecular-weight heparin. Control Doppler sonog-
raphy performed 6 months later demonstrated good flow 
through the inferior vena cava and both iliac veins. Of 
note, there were no features of thrombophilia in labora-
tory investigation of the coagulation system. 
DISCUSSION
Deep venous thrombosis is rarely seen in children. Its 
prevalence is at least 100-times less frequent than that of 
adults. Usually neonates and adolescents are affected and 
thrombosis is typically associated with the use of intrave-
nous catheters or severe morbidities (sepsis, cancer, heart 
disease, etc.). Anatomic abnormalities, primarily aplasia of 
the inferior vena cava and May-Thurner syndrome, and/
or disturbances of the coagulation syndrome can also be 
of an importance [1-7]. Unprovoked thrombosis in a child, 
such as in our patient is extremely rare. Current guidelines 
suggest conservative management of paediatric deep vein 
thrombosis. An invasive treatment can be performed only 
in children presenting with severe and limb-threatening 
thrombosis [1-3, 8]. Usually such a  treatment consists of 
local administration of fibrinolytics. Recently, percutane-
ous mechanical thrombectomy with the use of different 
devices (such as AngioJet [Boston Scientific, Natick, MA, 
USA] or Trellis-8 [Covidien, Mansfield, MA, USA]), has 
been added to the armamentarium [8-10]. Our paper on 
the use of the Aspirex®S, to the best of our knowledge, 
is the first report of a successful use of this endovascular 
device for the treatment of deep vein thrombosis in a child. 
Pulmonary embolism appears to be the most important 
complication associated with endovascular thrombectomy 
of the iliac veins and the inferior vena cava. Some authors 
used prophylactic cava filters in patients with occluded ili-
ac veins but patent vena cava [8, 10]. In our patient the use 
of such a filter was not possible, since the inferior vena cava 
was totally closed by the thrombus. Local administration 
of alteplase improves the results of venous thrombectomy 
in paediatric patients and is associated with acceptable low 
rate of bleeding adverse events (less than 20%), which are 
usually of minor clinical relevance [8, 10].
CONCLUSIONS
Although most children presenting with deep vein 
thrombosis can be managed conservatively, in cases of 
Fig. 2. A) Control venography – patent inferior vena cava (1). B) residual stenotic lesions in the left iliac veins (2). C) Recanalisation 
of the left internal iliac vein (3) – there was a good outflow from pelvic veins. D) Clinical improvement after first procedure – reduc-
tion of oedema of the scrotum, penis and lower limbs. E) Final clinical effect – no swelling of the left lower limb and scrotum
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severe and limb-threatening thrombosis endovascular 
mechanical thrombectomy combined with local intrave-
nous administration of a fibrinolytic agent seems to be 
a  safe and efficient alternative. 
The authors declare no conflict of interest.
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